ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Reciprocal interactions between tumor killer dendritic cells and tumor-induced regulatory T lymphocytes||University of Arizona / Nicolas Larmonier, PhD||Young Investigator Grants||2008||Arizona|
|Genomic Alterations in Medulloblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Young Investigator Grants||2008||California|
|Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors||Harbor - UCLA Medical Center / Joseph Lasky||Young Investigator Grants||2008||California|
|Blockade of Mycn in neuroblastoma||University of California San Francisco / William Weiss||Innovation Grants||2008||California|
|Application of Epigenetic Markers for Early Detection of Childhood Leukemia.||University of California San Francisco / Sheng Zhong||Epidemiology Grants||2008||California|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|
|Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors||Children's Hospital Los Angeles / William May||Innovation Grants||2008||California|
|New Approaches to Neuroblastoma Therapy||Children's Hospital Los Angeles / Robert Seeger||Phase I/II Infrastructure Grants||2008||California|
|Inhibition of Cathepsins to Treat Neuroblastoma||Alfred I duPont Hospital for Children / Robert Mason||Innovation Grants||2008||Delaware|
|PI-3 kinase as a novel and attractive target in pediatric cancer and neuroblastoma||Emory University / Donald Durden||Innovation Grants||2008||Georgia|